Leverage magnifies whatever a business is already doing. This scan looks for the unfavourable case: debt at four times EBITDA or more, earnings declining year-over-year, and EBITDA margins shrinking at the same time. Debt service is a fixed obligation while earnings are not, so a company carrying that ratio into a downturn has less and less room between what it earns and what it owes.
Matches as of · delayed 14 days · Live on Super Pro
| Ticker | Company | Sector | Market cap | Price today | Change today |
|---|---|---|---|---|---|
| MRK | Merck & Co., Inc. | Manufacturing | $347.7B | $150.18 | +2.63% |
| GILD | Gilead Sciences Inc | Manufacturing | $197.4B | $171.47 | +3.54% |
| PFE | Pfizer Inc. | Manufacturing | $167.9B | $30.46 | +1.70% |
| ENB | Enbridge, Inc | Transportation, Communications, Electric, Gas, And Sanitary Services | $108.2B | $49.38 | +0.22% |
| GM | General Motors Company | Manufacturing | $70.0B | $87.38 | +1.94% |
Showing the top 5 of 156 matches. See all matches on the Super Pro plan.
This scan uses filters from the Super Pro plan. Load it as a preset, adjust any filter, and run it against live market data.
View pricing